4 results on '"Trabert B"'
Search Results
2. Testicular cancer among US men aged 50 years and older.
- Author
-
Ghazarian AA, Rusner C, Trabert B, Braunlin M, McGlynn KA, and Stang A
- Subjects
- Aged, Aged, 80 and over, Ethnicity statistics & numerical data, Humans, Incidence, Male, Middle Aged, Racial Groups statistics & numerical data, Registries, Risk Factors, Seminoma pathology, Spermatocytes pathology, United States, Neoplasms, Germ Cell and Embryonal epidemiology, Seminoma epidemiology, Testicular Neoplasms epidemiology
- Abstract
Background: The incidence of testicular cancer in the United States (US) has substantially increased in recent decades. The majority of testicular cancers are germ cell tumors (TGCT), which are the most commonly occurring malignancies among men aged 15-44 years in the US. To date, few studies have focused on testicular cancer among men aged ≥ 50 years. Thus, we sought to examine detailed descriptive features, including incidence rates and age patterns, of tumors that arise in the testes among men aged ≥ 50 years., Methods: Data from forty-one US cancer registries were included for the years 1999-2014. Incidence rates per 100,000 person-years and their 95% confidence intervals (CI) were calculated by race/ethnicity, histology, and age at diagnosis. Estimates of annual percent change (APC) were also calculated., Results: Age-specific incidence rates of spermatocytic tumors, sex cord stromal tumors and lymphomas rose with age, while age-specific incidence rates of seminomas and nonseminomas declined. Between 1999 and 2014, the incidence of nonseminoma (APC = 3.26, 95% CI: 2.27-4.25) increased more than any other tumor type. The incidence of seminoma (APC: 1.15, 95% CI: 0.59-1.71) also increased, while rates of testicular lymphoma (APC: -0.66, 95% CI: -1.16 to -0.16), spermatocytic tumors (APC: 0.42, 95% CI: -1.42 to 2.29), and sex cord stromal tumors (APC: 0.60, 95% CI: -3.21 to 4.55) remained relatively unchanged., Conclusion: Given the distinct time-trends and age-specific patterns of testicular cancer in men aged ≥50 years, additional investigation of risk factors for these tumors is warranted., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
3. Recent changes in endometrial cancer trends among menopausal-age U.S. women.
- Author
-
Wartko P, Sherman ME, Yang HP, Felix AS, Brinton LA, and Trabert B
- Subjects
- Adult, Age Factors, Aged, Female, Humans, Incidence, Middle Aged, Obesity complications, Obesity epidemiology, Overweight complications, Overweight epidemiology, SEER Program, Time Factors, United States epidemiology, Young Adult, Endometrial Neoplasms epidemiology, Estrogen Replacement Therapy trends, Menopause
- Abstract
Background: Changes in endometrial cancer incidence rates after the precipitous decline in menopausal hormone therapy (MHT) use in 2002 have not been evaluated., Methods: Using data from the Surveillance, Epidemiology, and End Results Program from 1992 to 2009 (SEER 13), we identified 63428 incident endometrial cancer cases among women ages 20-74. We compared annual percent change (APC) in endometrial cancer incidence rates from 1992 to 2002 to rates from 2003 to 2009., Results: In contrast to the constant endometrial cancer rate pattern observed from 1992 to 2002 (APC 0.0%), rates increased after 2002 in women 50-74 years old (2.5%; PAPC comparison<0.01). Endometrial cancer incidence increased over the entire time period among women ages 20-49 (1992-2002: 1.1%; 2003-2009: 2.1%; PAPC comparison=0.21). Post-2002 increases in incidence among women ages 50-74 were specific to Type I endometrial tumors (1992-2002: -0.6%; 2003-2009: 1.6%; PAPC comparison<0.01)., Discussion: The increase in endometrial cancer incidence rates after 2002 may be related to the widespread decrease in estrogen plus progestin MHT use, which has been reported to lower endometrial cancer risk in overweight and obese women., (Published by Elsevier Ltd.)
- Published
- 2013
- Full Text
- View/download PDF
4. Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008.
- Author
-
Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, and Stang A
- Subjects
- Adolescent, Adult, Age Distribution, Aged, Aged, 80 and over, Female, Germany epidemiology, Humans, Incidence, Male, Middle Aged, Neoplasms, Germ Cell and Embryonal pathology, Ovarian Neoplasms pathology, Population Surveillance, Registries, Sex Factors, Testicular Neoplasms pathology, Time Factors, Young Adult, Neoplasms, Germ Cell and Embryonal epidemiology, Ovarian Neoplasms epidemiology, Testicular Neoplasms epidemiology
- Abstract
Background: Malignant gonadal (GGCT) and extragonal germ cell tumors [GCT (EGCT)] are thought to originate from primordial germ cells. In contrast to well reported population-based data of GGCTs in males, analyses of GGCTs in females and EGCTs in both sexes remain limited., Methods: In a pooling project of nine population-based cancer registries in Germany for the years 1998-2008, 16,883 malignant GCTs and their topographical sites were identified using ICD-O morphology and topography for persons aged 15 years and older. We estimated age-specific and age-standardized incidence rates., Results: Among males, the incidence of testicular GCTs increased over time. In contrast, there was no increase in the incidence of EGCTs. Among females, rates of ovarian GCTs were stable, while rates of EGCTs declined over time. The most frequent extragonadal sites were mediastinum among males and placenta among females., Conclusions: Our results underline different incidence trends and distinct age-specific incidence patterns of malignant GGCTs and EGCTs, as reported recently by several population-based registries. The differences suggest that GGCT and EGCT may have different etiologies., (Copyright © 2013 Elsevier Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.